探讨mTOR-Tudor-SN信号通路在心肌缺血再灌注损伤中的心肌保护作用机制

批准号:
81970210
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
魏民新
依托单位:
学科分类:
心肌损伤、修复、重构和再生
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
魏民新
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
心肌缺血再灌注损伤(MIRI)是阻碍心血管疾病治疗及预后的难题。mTOR通路在MIRI中发挥重要保护作用。课题组发现多功能Tudor-SN蛋白是mTOR通路的新靶分子,在心肌细胞分化成熟中发挥调控作用。基于前期工作基础,我们提出假设,mTOR/Tudor-SN/YAP在MIRI中发挥心肌保护作用。MIRI中mTOR通路激活后上调Tudor-SN,随后Tudor-SN调控YAP促进心肌修复,并通过抗凋亡及氧化应激的作用抵抗损伤,保护心肌。本课题将利用Tudor-SN转基因、敲除及野生型小鼠构建MIRI模型:1.明确MIRI下mTOR通路激活对Tudor-SN表达调控作用。2.探索Tudor-SN调控YAP入核,促进心肌细胞增殖及再生,发挥心脏保护作用机制。3.从基因转录调控水平探讨Tudor-SN蛋白调控心肌氧化应激和凋亡的机制。本研究将为深入探讨临床MIRI的治疗及预防提供理论基础。
英文摘要
Myocardial ischemia reperfusion injury (MIRI) is a major obstacle in treatment and prognosis of cardiovascular diseases. mTOR signaling pathway plays an important protective role in MIRI. Recently, we demonstrated that multifunctional Tudor-SN protein , as a new target molecule of mTOR signaling pathway, involves in the regulation of development and maturation of cardiac myocytes. Based on previous work, we hypothesize that mTOR/Tudor-SN/YAP signaling pathway may participate in myocardial protection under MIRI. The possible mechanisms are as follows: mTOR pathway is activated under MIRI, and then upregulates the expression of Tudor-SN. Tudor-SN then promotes myocardial reparation through inducing YAP nuclear location. Meanwhile, Tudor-SN may protect the myocardium through regulating apoptosis and oxidative stress. In this project, we will investigate the underlying molecular mechanisms of Tudor-SN in cardiac protection under MIRI. Tudor-SN-KO, TG and WT C57BL/6N mices will be utilized to build the MIRI model. We'll detect the activity of mTOR pathway and the expression of Tudor-SN under MIRI. Then, we'll explore the mechanism of Tudor-SN promotes myocardial cell proliferation and regeneration under MIRI through regulating the location of YAP protein. Meanwhile we'll detect the influence of Tudor-SN on oxidative stress, stress granules formation and apoptosis in mice MIRI model and H9c2 cell lines, and reveal the underlying mechanism through transcriptional regulation. This study will provide new therapeutic targets and strategies to the clinical treatment and prevention of MIRI .
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1007/s11356-021-15846-7
发表时间:2021-08
期刊:Environmental Science and Pollution Research
影响因子:5.8
作者:Xiao Ke;W. Guo;Yanren Peng;Zongming Feng;Yi-teng Huang;Ming Deng;M. Wei;Zanxin Wang
通讯作者:Xiao Ke;W. Guo;Yanren Peng;Zongming Feng;Yi-teng Huang;Ming Deng;M. Wei;Zanxin Wang
DOI:--
发表时间:2022
期刊:中国心血管杂志
影响因子:--
作者:马锦征;苏超;杨洁;魏民新
通讯作者:魏民新
DOI:10.1007/s00018-023-05095-x
发表时间:2024-01-27
期刊:CELLULAR AND MOLECULAR LIFE SCIENCES
影响因子:8
作者:Su, Chao;Liu, Mingxia;Yao, Xuyang;Hao, Wei;Ma, Jinzheng;Ren, Yuanyuan;Gao, Xingjie;Xin, Lingbiao;Ge, Lin;Yu, Ying;Wei, Minxin;Yang, Jie
通讯作者:Yang, Jie
DOI:10.1089/dna.2020.5506
发表时间:2020-09
期刊:DNA and cell biology
影响因子:3.1
作者:Zanxin Wang;X. Zhuang;Bailang Chen;Dongjie Feng;Gang Li;M. Wei
通讯作者:Zanxin Wang;X. Zhuang;Bailang Chen;Dongjie Feng;Gang Li;M. Wei
DOI:10.3892/mmr.2020.11703
发表时间:2020-11
期刊:Molecular medicine reports
影响因子:3.4
作者:Zanxin Wang;X. Zhuang;Bailang Chen;M. Wei
通讯作者:Zanxin Wang;X. Zhuang;Bailang Chen;M. Wei
血管损伤诱导Elk1-Tudor-SN-SRF信号轴参与血管狭窄的机制探讨
- 批准号:82170435
- 项目类别:面上项目
- 资助金额:55万元
- 批准年份:2021
- 负责人:魏民新
- 依托单位:
国内基金
海外基金
